A year ago, most AI conversations in healthcare sounded the same: “We’re piloting,” “We’re exploring,” “We’re waiting for evidence.” In 2025, that tone shifted. Not because the hype got louder—but because ROI finally got clearer.
Across provider and payer organizations, we saw AI move from isolated proofs of concept to targeted deployments tied to measurable outcomes: fewer denials, faster prior auth, shorter documentation cycles, improved patient access, and operational savings that CFOs can actually recognize. Industry leaders have reported annualized savings ranging from $20M to $100M+ in some large-scale deployments, alongside measurable quality and safety gains. (Becker’s Hospital Review)
From my seat—leading healthcare solution strategy and helping buyers build business cases—the story of “ROI on AI” in the last year is really a story of where AI was applied and how tightly it was connected to workflow + metrics.
Below is what we learned, where ROI showed up fastest, and how to evaluate it without hand-waving.
What Changed in 2025: From Pilots to Production Economics
Two things became true at the same time:
Pressure intensified (labor shortages, margin compression, administrative burden). Deloitte’s healthcare executive outlook highlighted that operational efficiency and productivity gains were top priorities for health system leaders. (Deloitte)
AI got more deployable (better integrations, clearer governance patterns, and “agent-like” automation). McKinsey’s 2025 global survey noted that many organizations were still experimenting, but roughly one-third had begun to scale AI, and agentic AI started moving from concept to real deployment. (McKinsey & Company)
The result: more buyers stopped asking, “Does AI work?” and started asking, “Where does AI pay back first?”
The 5 ROI Buckets That Showed the Fastest Payback
1) Revenue Cycle: Denials, Documentation, Coding, Collections
If you want short payback cycles, this is where most organizations landed first—because the economics are direct, measurable, and already tracked.
KLAS reported that providers refocused AI investments toward RCM and that both payers and providers are moving from exploration to execution—70% of providers and 80% of payers have AI strategies underway. (KLAS Research)
Where ROI showed up:
Cleaner documentation → fewer downstream denials
Automation of repetitive claim work queues
Better coding support and faster charge capture
Reduction in manual touches per claim
How to measure it:
Denial rate reduction (baseline vs. post)
Days in A/R
Cost-to-collect
Net revenue uplift attributable to fewer write-offs
FTE hours avoided or redeployed
Practical note: The highest performers didn’t “add AI” on top of broken processes—they redesigned workflows around it. That lines up with broader findings that workflow redesign is a key factor in achieving meaningful AI impact. (McKinsey & Company)
2) Prior Authorization and Utilization Management
On the payer side—and increasingly in payer-provider collaboration—prior auth has become one of the most hated (and most expensive) processes. It’s also ripe for AI, because much of the effort is document processing, policy matching, summarization, and repetitive communications.
KLAS noted growing interest in AI-driven tools for prior authorization and call center efficiency, and “promising win-win outcomes” in payer-provider pilots. (KLAS Research)
Where ROI showed up:
Reduced turnaround time (TAT)
Fewer incomplete submissions
Higher first-pass approval rates
Lower administrative cost per authorization
How to measure it:
Average PA cycle time
Touches per case
% auto-approved or “fast-laned” cases
Provider abrasion metrics (complaints, escalations)
3) Ambient Documentation + Clinical Admin Time
Ambient AI (scribes/listening) delivered real value in 2025—but with an important nuance: time savings can look small per note, yet large in aggregate, and outcomes vary by specialty, workflow, and adoption.
One analysis discussed an 8.5% reduction in documentation time, noting that saving only a couple minutes per patient can translate into multiple hours per week for busy clinicians. (Advisory Board)
Peer-reviewed research has also examined ambient scribe impact on documentation time and quality in simulated inpatient settings. (PubMed)
Where ROI showed up:
Fewer hours in pajama time
Reduced burnout and cognitive load (often a leading indicator of retention improvements)
Increased visit capacity in some settings (when schedule templates are adjusted)
How to measure it:
Minutes saved per encounter × encounters/week × clinicians
After-hours EHR time
Clinician satisfaction and retention risk indicators
Patient experience (especially “felt listened to” measures)
Reality check: Not every implementation produces dramatic savings immediately. ROI improves when you pair the tool with template optimization, training, and downstream automation (orders, referrals, follow-ups).
4) Patient Access and Contact Center Operations
This one surprised some executives because it isn’t “clinical AI,” but it consistently delivered clean ROI: fewer calls, better routing, shorter handle times, and improved conversion from inquiry to appointment.
A 2025 industry report commissioned by Google Cloud found 73% of healthcare and life sciences leaders reported positive returns within the first year from gen AI initiatives, with strong ROI use cases including tech support and patient experience. (Google Cloud)
Where ROI showed up:
Reduced call volume through better self-service
Lower average handle time (AHT)
Improved scheduling fill rates
Fewer no-shows through smarter outreach
How to measure it:
Cost per scheduled appointment
AHT and first-call resolution
Abandonment rate
Leakage reduction (kept in-network)
5) Quality, Safety, and Throughput (The “Harder-to-Price” ROI)
Some of the most meaningful impact is clinical and operational: early deterioration detection, better sepsis surveillance, improved discharge planning, and smarter bed management. Becker’s highlighted 2025 examples where AI value went beyond cost—into quality and safety outcomes—alongside major cost reductions at scale. (Becker’s Hospital Review)
Where ROI showed up:
Reduced length of stay in targeted cohorts
Avoided adverse events
Improved throughput and capacity management
Better compliance and documentation completeness
How to measure it:
Avoidable days
Complication rates and readmissions
Capacity unlocked (beds, OR time, infusion chairs)
Financial impact tied to quality programs and penalties
The ROI Framework We Recommend to Healthcare Leaders
When we help organizations evaluate AI investments, we steer away from “AI value” in the abstract and focus on ROI mechanics:
Step 1: Define the “Unit of Improvement”
Examples:
cost per claim
minutes per note
days in A/R
authorizations per UM nurse per day
contact center cost per scheduled visit
Step 2: Quantify Benefit in 3 Layers
Hard dollars (revenue lift, expense reduction)
Capacity created (time returned that can be redeployed)
Risk reduction (compliance, safety, security, reputation)
Step 3: Include the Full Cost to Realize Value
AI ROI can be overstated if you ignore:
integration and workflow redesign
change management and training
governance, monitoring, and human validation processes (McKinsey & Company)
ongoing model tuning and maintenance
Step 4: Track Time-to-Value and Adoption
A solution can be “accurate” and still fail ROI if adoption stalls. The best programs treat deployment like an operational transformation—not a software install.
The Bottom Line: 2025 Was the Year ROI Became Specific
In the last year, ROI on AI healthcare solutions became less about promises and more about targeted outcomes:
RCM and administrative automation produced some of the clearest short-term returns. (KLAS Research)
Ambient documentation produced meaningful aggregate time value—especially when paired with workflow optimization. (Advisory Board)
Patient access, support, and service operations quietly delivered some of the most reliable ROI curves. (Google Cloud)
At scale, organizations reported savings in the tens of millions—sometimes more—alongside quality improvements. (Becker’s Hospital Review)
If you’re evaluating AI in 2026, my candid recommendation is this: don’t start with “AI strategy.” Start with one measurable operational constraint, define the unit economics, and deploy AI only where it can move a metric you already track
Comments are closed